NCT04421170

Brief Summary

This study aims to evaluate the efficacy of cognitive behavioral therapy (CBT)-based cigarette smoking cessation smartphone app for treatment seeking smokers in China.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,289

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 4, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
9 months until next milestone

Study Start

First participant enrolled

February 23, 2021

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2023

Completed
Last Updated

November 3, 2023

Status Verified

November 1, 2023

Enrollment Period

2.1 years

First QC Date

June 4, 2020

Last Update Submit

November 1, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Biologically verified continuously smoking abstinence at week 26

    Participants in this study will be considered to be biologically verified continuously smoking abstinence if they report smoking no more than 5 cigarettes since the quit date and have an expired carbon monoxide concentration of less than 10 ppm (for local participants who will be able to go to the PI affiliated hospital) or a urine cotinine cutoff point of 200 ng/ml (cotinine urine dipsticks will be mailed to each participant's address, and test will be confirmed by video call and by family members) at week 26 (6 months) after quit date. This abstinence has been applied by the Society for Research on Nicotine and Tobacco (SRNT) (Hughes, Keely et al. 2003) and the 'Russell Standard' (West, Hajek et al. 2005).

    26 weeks

Secondary Outcomes (3)

  • 7-day point prevalence smoking abstinence

    26 weeks

  • Self-reported continuous smoking abstinence

    26 weeks

  • Reductions in number of cigarettes smoked per day

    26 weeks

Study Arms (2)

Intervention Group

EXPERIMENTAL

Participants from the intervention group will receive CBT based smoking cessation. It provides both mandatory information of evidence-based and guideline-based smoking cessation interventions, and optional information about quitting benefits, tips for quitting et al. The app will be available for the participants in the intervention group until 26-week post-quit date follow-up. After this period, the app will automatically stop the data collection, but they can continue to use it if they want. As the participants progressed through the study, smoking cessation related information will be gradually reduced until 12 weeks after quit date, and follow-up messages will be sent at 16, 20 and 26 weeks after quit date. Participants from intervention group can also seek for help at any time by text or WeChat, or make a phone call.

Behavioral: smartphone app for smoking cessation

Control group

NO INTERVENTION

Participants from the control group will only receive information of thanking them for being in the study and reminding them of the time until their free month at the end of follow up. In order to measure the outcomes between two groups, continuous smoking abstinence, point prevalence of abstinence, how many cigarettes per day during the last week if they are still smoking will be checked at week 1, 2, 3, 4, 8, 12, 16, 20 and 26 points after quit date by ePRO software. Biochemically verified continuously abstinence will also be checked if they have reported continuous smoking abstinence at week 26 points after quit date.

Interventions

Paticipants will receive 12-week app-based smoking cessation intervention with follow-up to 26 weeks.

Intervention Group

Eligibility Criteria

Age25 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Cigarette smokers (smoked more than 100 cigarettes in their lifetime, and currently smoke five or more cigarettes a day)
  • years of age or older
  • Being able to read and write in Chinese
  • Owning a smartphone
  • Have experience of using apps
  • Expressing an interest in quitting smoking within the next month
  • Willing to provide informed consent to participate in the study

You may not qualify if:

  • Nonsmokers
  • Only use electronic cigarettes
  • Smokers without attempts to quit smoking
  • Participants with severe mental illness
  • Participants who had already started their quit attempt or using any smoking cessation treatment at the time of registration
  • Unable to use smartphone and apps
  • Unable to read and write in Chinese

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yanhui Liao

Hangzhou, Zhejiang, 310016, China

Location

Related Publications (2)

  • Chen S, Tang J, Wu C, Zhang G, Zhang J, Liao Y. Preliminary Efficacy of a Cognitive Behavioral Therapy-Based Smartphone App for Smoking Cessation in China: Randomized Controlled Pilot Trial. JMIR Form Res. 2024 Mar 18;8:e48050. doi: 10.2196/48050.

  • Liao Y, Tang J. Efficacy of cognitive behavioural therapy-based smartphone app for smoking cessation in China: a study protocol of a randomised controlled trial. BMJ Open. 2021 Jan 13;11(1):e041985. doi: 10.1136/bmjopen-2020-041985.

MeSH Terms

Conditions

Cigarette Smoking

Condition Hierarchy (Ancestors)

Tobacco SmokingSmokingBehaviorTobacco Use

Study Officials

  • Yanhui Liao, MD

    Department of Psychiatry, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 4, 2020

First Posted

June 9, 2020

Study Start

February 23, 2021

Primary Completion

April 15, 2023

Study Completion

April 15, 2023

Last Updated

November 3, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will share

All collected IPD, all IPD that underlie results in a publication.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Starting 1 month after publication.
Access Criteria
Yanhui Liao will review requests and criteria for reviewing requests

Locations